Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
774.90B
Market cap774.90B
Price-Earnings ratio
54.80
Price-Earnings ratio54.80
Dividend yield
0.70%
Dividend yield0.70%
Average volume
2.48M
Average volume2.48M
High today
$829.46
High today$829.46
Low today
$814.05
Low today$814.05
Open price
$824.00
Open price$824.00
Volume
1.83M
Volume1.83M
52 Week high
$935.63
52 Week high$935.63
52 Week low
$623.78
52 Week low$623.78

LLY News

TipRanks 1h
Lilly partners with Nvidia to build AI supercomputer, medicine discovery

Eli Lilly (LLY) announced it is building “the most powerful supercomputer owned and operated by a pharmaceutical company,” in collaboration with Nvidis (NVDA)....

CNBC 1h
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development

Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025. Eli Lilly and Nvidia are par...

Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development
Seeking Alpha 7h
Eli Lilly readies billions of weight-loss pills ahead of U.S. approval

Eli Lilly (NYSE:LLY) has already manufactured billions of doses of its next-generation weight-loss pill, anticipating strong global demand ahead of a potential...

Eli Lilly readies billions of weight-loss pills ahead of U.S. approval

Analyst ratings

77%

of 31 ratings
Buy
77.4%
Hold
19.4%
Sell
3.2%

More LLY News

Simply Wall St 7h
FDA OKs Once-Monthly Omvoh Injection Could Be a Game Changer for Eli Lilly

Eli Lilly and Company recently received U.S. FDA approval for a once-monthly, single-injection maintenance regimen of Omvoh (mirikizumab) for adults with modera...

FDA OKs Once-Monthly Omvoh Injection Could Be a Game Changer for Eli Lilly
Bloomberg 8h
Eli Lilly Makes Billions of Weight-Loss Pills Before US Approval

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch n...

Eli Lilly Makes Billions of Weight-Loss Pills Before US Approval
TipRanks 14h
Jim Cramer Says One Stock Is Poised to Hit $1 Trillion Soon — Can You Guess Which?

Jim Cramer, the host of CNBC’s Mad Money, shared his outlook on the next group of U.S. companies likely to reach the $1 trillion mark. He named JPMorgan Chase (...

TipRanks 21h
Eli Lilly’s New Study on Pirtobrutinib: A Long-Term Safety Evaluation

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...

TipRanks 21h
Eli Lilly’s New Phase 3 Trial: A Potential Game-Changer in Bladder Cancer Treatment

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

TipRanks 1d
Eli Lilly’s Latest Study on Abemaciclib: A Potential Game-Changer in Pediatric Cancer Treatment

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...

TipRanks 1d
Eli Lilly’s Orforglipron Study: A Potential Game-Changer in Diabetes Treatment

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.